Provided by Tiger Trade Technology Pte. Ltd.

ASCLETIS-B

10.020
-0.080-0.79%
Volume:2.08M
Turnover:20.50M
Market Cap:10.54B
PE:-27.07
High:10.020
Open:9.965
Low:9.515
Close:10.100
52wk High:19.860
52wk Low:7.950
Shares:1.05B
HK Float Shares:1.05B
Volume Ratio:1.27
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.370
ROE:-18.45%
ROA:-14.45%
PB:4.67
PE(LYR):-27.07
PS:4455.18

Loading ...

Is Ascletis Pharma (SEHK:1672) Undervalued On FDA Clearance For ASC35?

Simply Wall St.
·
Jun 24

ASCLETIS PHARMA CONDUCTS HK$2.02 MILLION SHARE BUYBACK

Stock News
·
Jun 24

Ascletis Pharma Gets US FDA Nod for Obesity Drug Trial

MT Newswires Live
·
Jun 23

ASCLETIS-B Receives FDA Clearance for Phase I Study of Its Monthly Subcutaneous GLP-1R/GIPR Dual Agonist Peptide ASC35 in Obesity

Stock News
·
Jun 23

Ascletis Announces U.S. FDA Ind Clearance for Phase I Study of Once-Monthly Subcutaneously Administered Glp-1R/Gipr Dual Peptide Agonist, Asc35, for the Treatment of Obesity

THOMSON REUTERS
·
Jun 23

Ascletis wins US FDA IND clearance for Phase I study of monthly obesity drug ASC35

Reuters
·
Jun 23

Ascletis Pharma - Receives U.S. FDA Ind Clearance for Phase I Study of Asc35 for Obesity

THOMSON REUTERS
·
Jun 23

HK Movers | Biotech Stocks Jump. InnoGen up over 17%; Alphamab, Hengrui Pharma, Laekna, Keymed Bio up Around 5%; Joinn, Remegen up About 4%

Tiger Newspress
·
Jun 23

ASCLETIS-B Executes Share Buyback on June 22, Spending HK$1.901 Million

Stock News
·
Jun 22

Ascletis Pharma files HKEX next-day return disclosing share repurchase for cancellation

Reuters
·
Jun 22

ASCLETIS-B Executes Share Buyback Totaling HK$1.97 Million

Stock News
·
Jun 17

Ascletis Pharma files HKEX next-day disclosure return on share repurchase for cancellation

Reuters
·
Jun 17

ASCLETIS-B Executes Share Buyback, Spending HK$1.86 Million

Stock News
·
Jun 16

Ascletis Pharma files HKEX next-day disclosure return reporting share repurchase for cancellation

Reuters
·
Jun 16

ASCLETIS-B Executes Share Buyback, Spending HK$1,918,300 on June 15

Stock News
·
Jun 15

Ascletis Pharma files HKEX next-day return disclosing share repurchase for cancellation

Reuters
·
Jun 15

One Ascletis Pharma Insider Has Reduced Their Stake

Simply Wall St.
·
Jun 13

Ascletis Pharma launches fresh HKD 1.97 million buyback; cumulative repurchases reach 7.89 million shares

Bulletin Express
·
Jun 11

ASCLETIS-B Executes HK$1.97 Million Share Buyback on June 11

Stock News
·
Jun 11

Ascletis Pharma Executes HKD 2.00 Million Share Buyback; Cumulative Repurchases Reach 7.69 Million Shares

Bulletin Express
·
Jun 10